Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Need-to-Know Numbers You Might Have Missed Last Week

Another year, another Thanksgiving. I hope all of my American friends and readers had the chance to spend some quality time with family as we begin the busy holiday shopping season. The leading retail trade group expects sales in November and December to increase as muc...

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...

Prospecting the Americas While Generating Real Shareholder Value

It’s not often a junior mining explorer is as geographically and minerally diversified in its property holdings as Alianza Minerals Ltd. (ANZ) ( TSX-V.ANZ , OTC:TARSF , Forum ). Then again, few mining companies are as progressive thinking in developing t...

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...

What is DehydraTECH and how is it revolutionizing solutions in cannabis and alcohol-free beverages?

Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the space where craft consumer products meet bioscience by leveraging its deep CP...

Revenues surge 5x with the continued deployment and expansion of DehydraTECH in US markets

See: Hill Incorporated Releases FY2023 Q3 Financial Results . Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the spa...

Calculate the Trading Strategies' Profitability like a Pro

Investors venture into cryptocurrency trading to gain profits. They employ customized trading strategies, portfolio management strategies, and progressive investment decisions throughout their trade. Due to the progressive nature of trading, tracking one&CloseCurlyQuote...

Has the Equities Waterfall Event Started Or A Buying Opportunity?

Over the past 5+ days, a very clear change in market direction has taken place in the US and global markets. Prior to this, the US markets were reacting to Q4 earnings data and minimizing the potential global pandemic of the Coronavirus. The continued “rally to the peak&Clos...

Campbell Soup Earnings Are Good Food for Investors

Now serving much more than just soup, shares of multi-brand food conglomerate Campbell Soup Co. are trading 10% higher today as the firm announced better than expected annual earnings. Shares of Campbell Soup Company (CPB:NYSE) are trading more than 10% higher today...

Oil demand high in Africa: Stockhouse TickerTrax

Stockhouse Ticker Trax is equity specific research (Canadian listed and market cap < $300 million) published every Monday to paid subscribers. Our free Friday column may feature companies previously featured to paid subscribers (with a minimum one month delay) or discuss ...
1 2 3 4 5 6 7